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ABSTRACT
Heterometrus xanthopus (Scorpion) is one of the most venomous and ancient arthropods. Its 
venom contains anti-microbial peptides like hadrurin, scorpine, Pandinin 1, and Pandinin 2 
that are able to effectively kill multidrug-resistant pathogens. The present study was 
conducted to evaluate the anti-bacterial activity of H. xanthopus venom. Six Gram-positive 
and Gram-negative bacterial strains were tested against 1/100, 1/10, and 1/1 fractions of 
distilled water diluted and crude venom. 1/100 and 1/10 dilutions were not successful 
in any of the six bacterial strains studied while the 1/1 dilution was effective on Bacillus 
subtilis ATCC 6633, Salmonella typhimurium ATCC 14028, and Pseudomonas aeruginosa 
ATCC 27853 with highest zone of inhibition were obtained on B. subtilis. Crude venom 
was effective against Enterococcus faecalis ATCC 14506, B. subtilis, S. typhimurium, and 
P. aeruginosa. The most effective results were observed on B. subtilis.
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Introduction
Scorpions are venomous arthropod animals belonging to the 
class Arachnida.[1] There are thirteen families and about 1,400 
described species and subspecies of scorpions.[2] All scorpions are 
venomous but approximately 50 of them have enough poison to kill 
a person.[3,4] The oldest known scorpions lived around 430 million 
years ago in the Silurian period, on the bottom of shallow tropical 
seas, hence  regarded as the oldest terrestrial arthropods.[5]
Venoms from scorpions are complex mixtures of compounds 
(neurotoxins, enzyme inhibitors, salts, etc.). Scorpions use 
venoms for immobilization of prey and protection against 
predators. Scorpion venoms consist of a complex of several 
toxins that exhibit a wide range of biological properties 
and actions, as well as chemical compositions, toxicity, 
pharmacokinetic, and pharmacodynamic characteristics.[6] 
Small basic proteins present in scorpion venoms are responsible 
for the neurotoxic activities of the venoms. Keeping in view of 
all these facts the present study was conducted to evaluate the 
antibacterial activity of Heterometrus xanthopus by utilizing 
curde and diluted venom.
Materials and Methods
Materials
All agars, sulphuric acid, barium chloride, sodium chloride, 
ethyl alcohol, nutrient broth, and other chemicals used in this 
study were of procured from Oxoid (UK), Fluka Chemika, and 
Difco Laboratories, USA.
Scorpion Procurement and Extraction Procedure
Scorpion (H. xanthopus) was collected by excavation from 
burrows in Mehra Alikhan, dry location in Haripur District, 
Khyber Pakhtunkhwa, Pakistan. The scorpions were fed on 
spiders, centipedes, grasshoppers, and cockroaches in glass 
cages (38W×58L×38H cm) with open tops for easy monitoring. 
Cage floor was covered up till four inches height with soil in 
order to provide natural habitat. These cages were kept at room 
temperature.[7]
Electricity control (12 V) Huawei AC/DC Adaptor (Model; 
UE4112005006) was used for venom extraction [Figure 1]. 
Venom was obtained from mature H. xanthopus from an opening 
near the tip of the bulb-shape venomous gland stinger by 
applying 12 V electrical stimulus. Electrical stimulus was applied 
by touching electrodes in the joints of last two segments of tail. 
One drop of sodium chloride solution was applied on each of 
these two joints to maximize flow of electricity. The venom was 
collected in 1.5 ml eppendorf tube.
Preparation of Venom Dilutions
Crude venom as well as 1/1, 1/10, and 1/100 dilutions 
were prepared in sterile distilled water. 1/1 diluted venom 
was prepared by mixing equal volume of venom and distilled 
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water. 1/10 diluted venom was prepared by mixing 1 part of 
venom with 9 parts of distilled water (v/v) while 1/100 diluted 
venom was prepared by mixing 1 part of venom with 99 parts 
of distilled water with the help of micropipette.
Gram-positive and Gram-negative bacterial strains
Reference bacterial strains, Staphylococcus aureus 
ATCC 6538, Enterococcus faecalis ATCC 49452, Escherichia 
coli ATCC 25922, Salmonella typhimurium ATCC 14028, 
Pseudomonas aeruginosa ATCC 27853, and Bacillus subtilis 
ATCC 19659 were obtained from American Type Culture 
Collection (ATCC) and were maintained on Nutrient agar slants 
(Oxoid, UK) at 4°C
Purity testing of each organism
Each organism is inoculated form working culture of 
nutrient broth (Merck) on their respective selective media for 
control as well as for purity testing, i.e., P. aeruginosa on (PCA) 
Pseudomonas Cetrimide Agar (Oxoid, CM0579), S. typhimurium 
on (XLD) Xylose Lysine Deoxycholate Agar (Oxoid, CM0469), S. 
aureus on (MSA) Mannitol Salt Agar (Oxoid, CM0085), E. faecalis 
on (S and B) Slanetz and Bartley (Oxoid, CM0377), E. coli on 
(EMB) Eosin Methylene Agar (Oxoid, CM0069), B. subtilis on 
Mannitol Egg Yolk Polymyxin Agar (MYP; Oxoid, CM0929) and 
incubated at 37°C for 24 h.
Evaluation of antimicrobial activity
After incubation, one colony of each bacterium from their 
respective selective agar medium was inoculated into 5 ml 
nutrient broth and incubated for 4-6 h at 37°C. The inocula 
were standardized by matching turbidity with a McFarland 
standard (No. 0.5). The test culture was spread evenly on the 
surface of pre-sterilized plastic petri dish containing solidified 
Mueller Hinton Agar (MHA; Oxoid CM 0337) with a sterile 
cotton swab. A total of 15 μl venom from eppendorf tube was 
dropped on the surface of each swabbed plate with the help 
of micropipette. These plates were then incubated at 37°C for 
24 h (Culture box, DH-2500). Resulting zones of inhibition were 
measured in centimeters for all bacterial plates after incubation. 
Same procedure was repeated for 1/1, 1/10, and 1/100 dilution.
Results
Antimicrobial activity of crude venom
Antimicrobial activity of crude venom was presented in 
Table 1. H. xanthopus crude venom was active against four 
bacterial strains. The clear zone of inhibition (30 mm) was seen 
against B. subtilis followed by S. typhimurium with 20 mm zone 
of inhibition. E. faecalis and P. aeruginosa showed (12 mm) each 
zone of inhibition on crude extract. However, the crude venom 
appeared to lack activity against the E. coli and S. aureus.
Inhibitory zone with 1/1, 1/10, and 1/100 diluted venom
1/1 diluted venom formed 30 mm zone of inhibition against 
B. subtilis showing no change of inhibition in comparison with 
crude venom [Figure 2]. P. aeruginosa showed zone of inhibition 
of 20 mm that was much higher than crude venom (12 mm). 
The possible reason for higher antibacterial activity is due to 
more activation of antibacterial peptides (AMP) in water in 
comparison with crude venom as previously described through 
RNA and DNA sequence by Gao et al.[8] 1/1 diluted venom 
showed 11 mm zone of inhibition against S. typhimurium. S. 
typhimurium showed reduced activity on 1/1 diluted venom in 
comparison with crude venom (20 mm). 1/1 diluted venom was 
found inactive against E. coli, E. faecalis, and S. aureus. Similar 
results of inactiveness of E. coli and S. aureus were seen on 
crude venom but in comparison a higher zone of inhibition of 
12 mm against E. faecalis was seen on crude venom.
All bacterial strains showed resistance against 1/10 and 
1/100 times diluted venom, with no zone of inhibition on Mueller 
Hinton Agar.
Discussion
Scorpion species often use to spray venom on their own 
bodies to disinfect them from possible saprophytic organisms 
Table 1:
Venom’s activity against bacteria with different concentrations
Bacterial Strain Crude venom 
inhibition zone
1/1 Dilution 
Inhibition zone
1/10 Dilution 
Inhibition zone
1/100 Dilution 
Inhibition zone
B. subtilis 30 ± 0.56 mm 30 ± 0.67 mm Nil Nil
E. coli Nil Nil Nil Nil
E. faecalis 12 ± 0.54 mm Nil Nil Nil
P. aeruginosa 12 ± 0.60 mm 20 ± 0.71 mm Nil Nil
S. aureus Nil Nil Nil Nil
S. typhimerium 20 ± 0.45 mm 11 ± 0.60 mm Nil Nil
B. subtilis=Bacillus subtilis, E.coli=Escherichia coli, E. faecalis=Enterococcus faecalis, P. aeruginosa=Pseudomonas aeruginosa, S. aureus=Staphylococcus aureus, 
S. typhimerium=Salmonella typhimerium
Figure 1: Milking venom from Heterometrus xanthopus scorpion by 
12V electric shock
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including bacteria and fungi, showing that venom of these 
scorpions could contain some sort of antibiotic potential.[9] 
Scorpion venom contains peptides which exhibit anti-microbial 
properties.[10,11] Kievit et al.[12] reported that an ingredient in 
the venom of the “deathstalker” scorpion could help in gene 
therapy for effective treatment for brain cancer. The scientists 
describe a new approach that could solve these problems. Key 
ingredients of their gene delivery system are chlorotoxin, the 
substance in deathstalker scorpion venom that can slow the 
spread of brain cancer, and nanoparticles of iron oxide.[12,13]
In this study, crude venom was effective against B. subtilis 
showed zone of inhibition 30 mm. These results are similar 
with that of spider venom activity reported by Benli and 
Yigit. [14] E. coli showed resistance against venom with no zone 
of inhibition is in relation with least effect of scorpion venom 
from southern Africa.[15] The results of E. faecalis showed 12 mm 
inhibition zone, Benli and Yigit[14] reported that E. faecalis was 
resistant against spider venom, whereas our finding indicates 
effectiveness of scorpion venom against E. faecalis. The results 
of P. aeruginosa are in comparison with Benli and Yigit.[14] 
S. aureus showed no zone of inhibition in our finding, whereas 
S. aureus showed zone of inhibition on spider venom.[14,16]
H. xanthopus venom with 1/1 dilution showed different 
results. The zone of inhibition of B. subtilis is identical to the 
results obtained from antibacterial study of two different spider 
species venom.[14,16] E. coli and S. aureus showed resistance 
against 1/1 diluted venom. These results are in comparison 
with results of San et al.[17] They obtained similar results with 
antimicrobial activity of venoms from snakes. 1/1 diluted venom 
made inhibition zone of 11 mm against S. typhimurium, while 9 
mm inhibition zone was reported against S. typhimurium when 
bee venom was tested against it.[18] All tested bacteria were 
found resistant to 1/10 and 1/100 diluted H. xanthopus venom. 
The possible reason behind this might because at some point 
when venom gets too much diluted the antibacterial activity 
subside.[14,18]
Conclusion
The data presented in the present research provides a strong 
base that venom peptide/protein is involved in antibacterial 
responses. This work paves the way for further characterizing 
immune related components involved in H. xanthopus venom, 
antibacterial response at the molecular level, which will 
undoubtedly expand our understandings in innate immunity. 
Polypeptide component’s involvement in antibacterial response 
of venom, offers clues for the search of new antibacterial 
template from scorpion resources for drug design and for high 
potential for clinical use.
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Figure 2: Venom’s activity against bacterial cultures with different 
concentrations
